Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - Coherus BioSciences, Inc. | d87814dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 6, 2015
COHERUS BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)
Delaware | 001-36721 | 27-3615821 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) |
201 Redwood Shores Parkway, Suite 200
Redwood City, CA 94065
(Address of principal executive offices, including Zip Code)
Registrants telephone number, including area code: (650) 649-3530
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 | Results of Operations and Financial Conditions |
On August 10, 2015, Coherus BioSciences, Inc. (the Company) issued a press release reporting its financial results for its second quarter ended June 30, 2015. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K.
This information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On August 6, 2015, the Compensation Committee of the Board of Directors of the Company approved the following annual base salaries, effective as of July 1, 2015 for the named executive officers of the Company, as identified the Companys final Prospectus related to its secondary public offering, which was filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on April 1, 2015:
Executive Name | Position | 2014 Base Salary | New Base Salary Effective July 1, 2015 |
|||||||
Dennis M. Lanfear | President & Chief Executive Officer | $ | 450,000 | $ | 561,700 | |||||
Barbara K. Finck, M.D | Chief Medical Officer | $ | 375,000 | $ | 407,500 | |||||
Alan C. Herman, Ph.D. | Chief Scientific Officer | $ | 350,000 | $ | 412,000 | |||||
Peter K. Watler, Ph.D. | Chief Technology Officer | $ | 335,000 | $ | 341,700 | |||||
Jean-Frédéric Viret, Ph.D. | Chief Financial Officer | $ | 350,000 | $ | 373,000 |
The Company will provide additional information regarding the compensation paid to the named executive officers for fiscal year 2015 in its definitive proxy statement for the 2016 Annual Meeting of Stockholders, which is expected to be filed with the Securities and Exchange Commission in the second quarter of 2016.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit No. |
Description | |
99.1 | Press Release dated August 10, 2015 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 10, 2015 | COHERUS BIOSCIENCES, INC. | |||
By: | /s/ Jean-Frédéric Viret | |||
Name: | Jean-Frédéric Viret | |||
Title: | Chief Financial Officer |
EXHIBIT INDEX
Exhibit No. |
Description | |
99.1 | Press Release dated August 10, 2015 |